Noviga Research (Sweden)

Noviga Research - Lidds

Noviga Research AB is a Swedish Pharma company focused on the development of novel effective pharmaceuticals for the treatment of advanced cancer. Noviga’s lead substance NOV202 will be evaluated in a 28-day regulatory toxicity study and safety pharmacology study followed by clinical Phase Ib/IIa study in patients with refractory cancer. An advisory meeting has been…